Folgen
Roland Wohlgemuth
Titel
Zitiert von
Zitiert von
Jahr
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone
R Sackstein, JS Merzaban, DW Cain, NM Dagia, JA Spencer, CP Lin, ...
Nature medicine 14 (2), 181-187, 2008
7242008
Biocatalysis—key to sustainable industrial chemistry
R Wohlgemuth
Current opinion in biotechnology 21 (6), 713-724, 2010
4312010
Orientation and flexibility of the choline head group in phosphatidylcholine bilayers
J Seelig, HU Gally, R Wohlgemuth
Biochimica et Biophysica Acta (BBA)-Biomembranes 467 (2), 109-119, 1977
2561977
Towards large-scale synthetic applications of Baeyer-Villiger monooxygenases
V Alphand, G Carrea, R Wohlgemuth, R Furstoss, JM Woodley
TRENDS in Biotechnology 21 (7), 318-323, 2003
2422003
Microscale technology and biocatalytic processes: opportunities and challenges for synthesis
R Wohlgemuth, I Plazl, P Žnidaršič-Plazl, KV Gernaey, JM Woodley
Trends in biotechnology 33 (5), 302-314, 2015
2122015
Guidelines for reporting of biocatalytic reactions
L Gardossi, PB Poulsen, A Ballesteros, K Hult, VK Švedas, Đ Vasić-Rački, ...
Trends in biotechnology 28 (4), 171-180, 2010
1752010
High-yield biocatalytic amination reactions in organic synthesis
J Ward, R Wohlgemuth
Current Organic Chemistry 14 (17), 1914-1927, 2010
1732010
Encyclopedia of industrial biotechnology: bioprocess, bioseparation, and cell technology, 7 Volume Set
MC Flickinger
City: John Wiley & Sons, ISBN, 2010
1672010
Bioeconomy for sustainable development
A Aguilar, T Twardowski, R Wohlgemuth
Biotechnology Journal 14 (8), 1800638, 2019
1642019
The use of enzymes in organic synthesis and the life sciences: perspectives from the Swiss Industrial Biocatalysis Consortium (SIBC)
HP Meyer, E Eichhorn, S Hanlon, S Lütz, M Schürmann, R Wohlgemuth, ...
Catalysis Science & Technology 3 (1), 29-40, 2013
1582013
Biocatalysis for Green Chemistry and Chemical Process Development
JA TAO, R KAZLAUSKAS
1452011
Asymmetric biocatalysis with microbial enzymes and cells
R Wohlgemuth
Current opinion in microbiology 13 (3), 283-292, 2010
1372010
Reactor operation and scale‐up of whole cell Baeyer‐Villiger catalyzed lactone synthesis
SD Doig, PJ Avenell, PA Bird, P Gallati, KS Lander, GJ Lye, ...
Biotechnology progress 18 (5), 1039-1046, 2002
1262002
Microbial transformations 59: First kilogram scale asymmetric microbial Baeyer‐Villiger oxidation with optimized productivity using a resin‐based in situ SFPR strategy
I Hilker, R Wohlgemuth, V Alphand, R Furstoss
Biotechnology and bioengineering 92 (6), 702-710, 2005
1252005
Microbial Transformations, 56. Preparative Scale Asymmetric Baeyer–Villiger Oxidation using a Highly Productive “Two‐in‐One” Resin‐Based in situ SFPR Concept
I Hilker, V Alphand, R Wohlgemuth, R Furstoss
Advanced Synthesis & Catalysis 346 (2‐3), 203-214, 2004
1232004
The headgroup conformation of phospholipids in membranes
G Büldt, R Wohlgemuth
The Journal of Membrane Biology 58, 81-100, 1981
1081981
Industrial biotechnology: sustainable growth and economic success
W Soetaert, EJ Vandamme
John Wiley & Sons, 2010
1052010
The locks and keys to industrial biotechnology
R Wohlgemuth
New Biotechnology 25 (4), 204-213, 2009
1022009
The first 200-L scale asymmetric Baeyer− Villiger oxidation using a whole-cell biocatalyst
CVF Baldwin, R Wohlgemuth, JM Woodley
Organic Process Research & Development 12 (4), 660-665, 2008
992008
Preparative scale Baeyer–Villiger biooxidation at high concentration using recombinant Escherichia coli and in situ substrate feeding and product removal process
I Hilker, MC Gutiérrez, R Furstoss, J Ward, R Wohlgemuth, V Alphand
Nature protocols 3 (3), 546-554, 2008
982008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20